亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Multiple Myeloma Cell Lines with Either Glucocorticoid Sensitivity and Resistance

技术优势
Allcell lines are derived from same patient
详细技术说明
Tissue culture cell lines derived from the peripheral blood of a multiple myeloma patient. #researchtool #cellline
*Abstract

Northwestern researchers have created tissue culture celllines derived from the peripheral blood of a multiple myeloma patient who hadbeen treated with glucocorticoids and become resistant to that treatment.  The blood was separated on a Ficoll gradientto isolate the compartment containing the myeloma cells. These isolated cellswere expanded in tissue culture and named MM.1 cells. The MM.1 parental cellline was further sub-cloned by limiting dilution to isolate cells that aresensitive to the killing effects of glucocorticoids. The resultant cells arenamed MM.1S.  The MM.1 parental cell linewas also treated with glucocorticoids at increasing doses over time and theresultant cells were not killed by high doses of glucocorticoids. These cellsare named MM.1R.  These cell lines havebeen widely used for the pre-clinical development of therapeutics designed totreat multiple myeloma. There are many other human myeloma cell lines inexistence, but these cell lines are unique in that bothglucocorticoid-sensitive and- resistant sub-clones were derived from the samepatient. This is a very attractive model for the study of how glucocorticoidresistance develops in patients.

*Inventors
Nancy KrettSteven Rosen*
*Publications
Goldman-LeikinRE, Salwen HR, Herst CV, et al. (1980) Characterization of a novel myeloma cellline. Journal of Laboratory ClinicalInvestigation.  113:  335-45.Moalli PA,Pillay S, Weiner D, Leikin R and Rosen ST (1992)  A mechanism of resistance to glucocorticoidsin multiple myeloma: transient expression of a truncated glucocorticoidreceptor mRNA.  Blood.  79:  213-22.
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备